Autologous tolerogenic dendritic cell therapy (Institute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus)

N/A

Report date: 2025/09/19 20:01:00

Base Information

Drug NameAutologous tolerogenic dendritic cell therapy (Institute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsDiabetes Mellitus

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelarus

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesInstitute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus

China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of Belarus

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus

Inactive IndicationsN/A

Other Information

ATC CodeN/A